BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37547825)

  • 1. Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves' disease.
    Gopinath C; Crow H; Panthi S; Bantis L; Burman KD; Choudhary C
    J Clin Transl Endocrinol; 2023 Sep; 33():100321. PubMed ID: 37547825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
    Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
    J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience.
    Ergin AB; Saralaya S; Olansky L
    Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Mekraksakit P; Rattanawong P; Karnchanasorn R; Kanitsoraphan C; Leelaviwat N; Poonsombudlert K; Kewcharoen J; Dejhansathit S; Samoa R
    Endocr Pract; 2019 Dec; 25(12):1323-1337. PubMed ID: 31412224
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
    Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
    Yuan L; Yang J
    J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidentally Discovered Papillary Thyroid Microcarcinomas Are More Frequently Found in Patients with Chronic Lymphocytic Thyroiditis Than with Multinodular Goiter or Graves' Disease.
    Paparodis RD; Karvounis E; Bantouna D; Chourpiliadis C; Chourpiliadi H; Livadas S; Imam S; Jaume JC
    Thyroid; 2020 Apr; 30(4):531-535. PubMed ID: 31950881
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric Thyroid Carcinoma in Patients with Graves' Disease: The Role of Ultrasound in Selecting Patients for Definitive Therapy.
    Kovatch KJ; Bauer AJ; Isaacoff EJ; Prickett KK; Adzick NS; Kazahaya K; Sullivan LM; Mostoufi-Moab S
    Horm Res Paediatr; 2015 Apr; ():. PubMed ID: 25896059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma.
    MacFarland SP; Bauer AJ; Adzick NS; Surrey LF; Noyes J; Kazahaya K; Mostoufi-Moab S
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2918-2925. PubMed ID: 29788090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and outcome of patients with Graves' disease and metastatic differentiated thyroid cancer.
    Besic N; Vidergar-Kralj B
    Radiol Oncol; 2023 Sep; 57(3):380-388. PubMed ID: 37665744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
    Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
    Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
    J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of papillary thyroid cancer in patients with Graves' disease: a propensity score-matched analysis.
    Kwon H; Moon BI
    World J Surg Oncol; 2020 Oct; 18(1):266. PubMed ID: 33050937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
    Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
    Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
    [No Abstract]   [Full Text] [Related]  

  • 17. Analyses of the molecular forms of serum thyroglobulin from patients with Graves' disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and Western blot.
    Druetta L; Croizet K; Bornet H; Rousset B
    Eur J Endocrinol; 1998 Nov; 139(5):498-507. PubMed ID: 9849814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
    Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
    Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
    Lu L; Gao C; Zhang N
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):303-309. PubMed ID: 32734611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy.
    Watanabe S; Okamoto S; Akikawa K; Miyamoto N; Okamura-Kawasaki M; Uchiyama Y; Takenaka J; Toyonaga T; Hirata K; Kudo K
    Ann Nucl Med; 2022 Nov; 36(11):923-930. PubMed ID: 35972673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.